 |
|
Surgical Treatment for Primary Hyperparathyroidism in Hong Kong—Invited Critique
Clive Grant, MD
Rochester, Minn
Arch Surg. 2004;139:82.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Lo et al have demonstrated convincingly that many characteristics of patients with primary HPT in Hong Kong mirror those seen in the Western world. Spanning the last 3 decades, more patients have been diagnosed as having less severe disease with fewer complications and symptoms. In contrast to many reports from Western countries, however, this change did not immediately follow the introduction of the blood chemistry multichannel autoanalyzer. In Hong Kong at least 7 years elapsed between the introduction of this technology and the notable rise in operative cases.
Valid epidemiological studies of the incidence and prevalence of primary HPT require medical information on a complete population including office and hospitalized patients managed both medically and surgically. Lo et al refer to excellent studies from Rochester, Minn, and Sweden. In contrast, the authors' data are derived from surgically treated patients and could be biased for the following reasons: . . . [Full Text of this Article]
RELATED ARTICLES
This Month in Archives of Surgery
Arch Surg. 2004;139(1):13.
FULL TEXT
Surgical Treatment for Primary Hyperparathyroidism in Hong Kong: Changes in Clinical Pattern Over 3 Decades
Chung-Yau Lo, Wai-Fan Chan, Annie W. C. Kung, King-Yin Lam, Sidney C. F. Tam, and Karen S. L. Lam
Arch Surg. 2004;139(1):77-82.
ABSTRACT
| FULL TEXT
|
